← Browse by Condition
Medical Condition

respiratory syncytial virus

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06754605 Phase 1, Phase 2
Recruiting

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine

Enrollment
480 pts
Location
China
Sponsor
Sinocelltech Ltd.
View Trial →